The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune biomarkers as predictors of response to mosunetuzumab in previously untreated follicular (FL) and marginal zone lymphoma (MZL).
 
Charles Milrod
Research Funding - Conquer Cancer, the ASCO Foundation
 
Anna Chorzalska
No Relationships to Disclose
 
John Morgan
No Relationships to Disclose
 
Makayla Pardo
No Relationships to Disclose
 
Christina Raker
No Relationships to Disclose
 
Thomas Ollila
Honoraria - adc the
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Loxo/Lilly (Inst); Ono Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Genentech
 
Ari Pelcovits
Consulting or Advisory Role - Avencell
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst)
 
Jessica McMahon
No Relationships to Disclose
 
Stephen Donnelly
No Relationships to Disclose
 
Caylee Carmody
No Relationships to Disclose
 
Frances Dallesandro
No Relationships to Disclose
 
Matthew Matasar
Stock and Other Ownership Interests - Merck
Honoraria - ADC Therapeutics; Bayer; Bristol-Myers Squibb/Celgene/Juno; Epizyme; Genentech; GlaxoSmithKline; Immunovaccine; Janssen; Pharmacyclics; Roche; Seagen; Takeda
Consulting or Advisory Role - Arvinas; Bayer; Daiichi Sankyo; Epizyme; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Takeda; Teva; Treeline Biosciences
Research Funding - Bayer; Genentech; GlaxoSmithKline; IGM Biosciences; IGM Biosciences; Immunovaccine; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Scott Huntington
Honoraria - AstraZeneca; BeiGene; Ipsen; Pharmacyclics; Seagen
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Arvinas; AstraZeneca; BeiGene; Epizyme; Flatiron Health; Genentech; Janssen; Merck; Novartis; SeaGen; TG Therapeutics; Tyme Inc.
Research Funding - Agios; Celgene; Debiopharm Group; DTRM; TG Therapeutics
Travel, Accommodations, Expenses - Genentech; Pharmacyclics; Seagen
 
Patrycja Dubielecka
No Relationships to Disclose
 
Adam Olszewski
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Blue Cross and Blue Shield of Rhode Island; Bristol-Myers Squibb; Genmab; Schrodinger
Research Funding - Artiva (Inst); Genentech/Roche (Inst); Genmab (Inst); Kymera (Inst); Kymera (Inst); Pfizer (Inst); Precision Biosciences (Inst)